Biocon Need Not Be Too Worried About U.S. Regulator’s Observations, Say Brokerages
A technician works at Biocon Ltd.’s cancer drug facility in Bangalore (Photographer: Namas Bhojani/Bloomberg)

Biocon Need Not Be Too Worried About U.S. Regulator’s Observations, Say Brokerages

Seven concerns raised by the U.S. drug regulator about Biocon Ltd.’s manufacturing facility in Bengaluru are mostly procedural and unlikely to be escalated into anything serious, according to broke...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.